about
AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine TumorsStudy of Pazopanib Monotherapy in Patients With Unresectable, Metastatic Neuroendocrine TumorCombination Targeted Radiotherapy in Neuroendocrine TumorsSafety Study of BEZ235 With Everolimus in Subjects With Advanced Solid TumorsA Multicenter Study Evaluating Efficacy and Safety of 177Lu-DOTA-TATE Based on Kidney-Dosimetry in Patients With Disseminated Neuroendocrine TumorsEverolimus Plus Best Supportive Care vs Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Neuroendocrine Tumors (GI or Lung Origin)Intra-arterial Lutetium-177-dotatate for Treatment of Patients With Neuro-endocrine Tumor Liver Metastases
P921
Q61921358-9EE53734-2B0B-4010-B877-E46CE64E08B1Q61936199-55318498-F305-4631-A26D-EA673B227DF4Q61936236-110302D6-D682-49C1-B547-5F417D8FB6A5Q61956630-4D483FD7-2CC8-4767-9FAF-F01FF4FC21BEQ61966086-3E9C6940-1064-44BB-BB77-A278F5E6027CQ63319144-90050F07-CA63-4753-B67F-B830C45FC374Q63599848-2C6AF521-DA04-41B9-9A41-4896987FC551
P921
description
Human disease
@en
Krankheit
@de
مرض يصيب الإنسان
@ar
name
intestinal neuroendocrine benign tumor
@en
type
label
intestinal neuroendocrine benign tumor
@en
altLabel
Intestinal Neuroendocrine Neoplasm
@en
Neuroendocrine Neoplasm of Intestine
@en
Neuroendocrine Neoplasm of the Intestine
@en
intestinal neuroendocrine benign tumor
@en
intestine neuroendocrine neoplasm
@en
intestine neuroendocrine tumor
@en
neuroendocrine tumor of Intestine
@en
prefLabel
intestinal neuroendocrine benign tumor
@en
P1748
P2892
P31
P5270
MONDO:0002883